160 related articles for article (PubMed ID: 35561459)
1. Generation of a human iPSC line CIBi010-A with a reporter for ASGR1 using CRISPR/Cas9.
Fu J; Jiang L; Yu B; Liu Y; Wei R; Hu Y; Ho WI; Yang B; Chu M; Tse HF; Yang J
Stem Cell Res; 2022 Jul; 62():102800. PubMed ID: 35561459
[TBL] [Abstract][Full Text] [Related]
2. Asialoglycoprotein receptor 1 is a specific cell-surface marker for isolating hepatocytes derived from human pluripotent stem cells.
Peters DT; Henderson CA; Warren CR; Friesen M; Xia F; Becker CE; Musunuru K; Cowan CA
Development; 2016 May; 143(9):1475-81. PubMed ID: 27143754
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
[TBL] [Abstract][Full Text] [Related]
4. Generation of an ASGR1 homozygous mutant human embryonic stem cell line WAe001-A-6 using CRISPR/Cas9.
Xu Y; Wu Y; Guo D; Gao G; Lai K; Yang F; Wang K; Wu H; Lai L; Li J; Xu K; Li YX
Stem Cell Res; 2017 Jul; 22():29-32. PubMed ID: 28952928
[TBL] [Abstract][Full Text] [Related]
5. Generation of a PXR reporter human induced pluripotent stem cell line (PXR-mCherry hiPSC) using the CRISPR/Cas9 system.
Kim H; Kim JW; Kim SJ; Choi YJ; Kim DS; Park HJ
Stem Cell Res; 2018 Jan; 26():72-75. PubMed ID: 29247817
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson's disease.
Wei R; Yang J; Cheng CW; Ho WI; Li N; Hu Y; Hong X; Fu J; Yang B; Liu Y; Jiang L; Lai WH; Au KW; Tsang WL; Tse YL; Ng KM; Esteban MA; Tse HF
JHEP Rep; 2022 Jan; 4(1):100389. PubMed ID: 34877514
[TBL] [Abstract][Full Text] [Related]
7. Generation of a PDGFRB-mCherry knock-in reporter human induced pluripotent stem cell line (KITi001-A-1), using CRISPR/Cas9 nuclease.
Jo S; Kim JW; Noh H; Kim H; Kim JH; Park HJ
Stem Cell Res; 2023 Jun; 69():103081. PubMed ID: 37001365
[TBL] [Abstract][Full Text] [Related]
8. Generation of Brachyury-mCherry knock-in reporter human pluripotent stem cell line (SNUe003-A-2) using CRISPR/CAS9 nuclease.
Jung J; Hwang S; Seol H; Kim AH; Lee HM; Sung JJ; Jeong SM; Choi YM; Jun JK; Kim DW; Jang J
Stem Cell Res; 2021 May; 53():102321. PubMed ID: 33878708
[TBL] [Abstract][Full Text] [Related]
9. Generation of a
Nouri P; Zimmer A; Brüggemann S; Friedrich R; Kühn R; Prakash N
Cells; 2022 Jan; 11(2):. PubMed ID: 35053384
[TBL] [Abstract][Full Text] [Related]
10. Establishment of TUBB3-mCherry knock-in human pluripotent stem cell line using CRISPR/Cas9 (SNUe003-A-4).
Kim AH; Lee HM; Kim HS; Jung J; Seol H; Choi E; Lee S; Min Choi Y; Jun JK; Kim HS; Jang J
Stem Cell Res; 2023 Jun; 69():103064. PubMed ID: 36913849
[TBL] [Abstract][Full Text] [Related]
11. Step-Wise Chondrogenesis of Human Induced Pluripotent Stem Cells and Purification Via a Reporter Allele Generated by CRISPR-Cas9 Genome Editing.
Adkar SS; Wu CL; Willard VP; Dicks A; Ettyreddy A; Steward N; Bhutani N; Gersbach CA; Guilak F
Stem Cells; 2019 Jan; 37(1):65-76. PubMed ID: 30378731
[TBL] [Abstract][Full Text] [Related]
12. Generation of a NESTIN-EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-1, using CRISPR/Cas9 nuclease.
Lee Y; Choi HY; Kwon A; Park H; Park M; Kim YO; Kwak S; Koo SK
Stem Cell Res; 2019 Oct; 40():101554. PubMed ID: 31499408
[TBL] [Abstract][Full Text] [Related]
13. Effect of Celecoxib on Differentiation of Human Induced Pluripotent Stem Cells into Hepatocytes Involves STAT5 Activation.
Okumura H; Nakanishi A; Hashita T; Iwao T; Matsunaga T
Drug Metab Dispos; 2018 Nov; 46(11):1519-1527. PubMed ID: 30158250
[TBL] [Abstract][Full Text] [Related]
14. Generation of a SOX9-tdTomato reporter human iPSC line, MCRIi001-A-2, using CRISPR/Cas9 editing.
Nur Patria Y; Lilianty J; Elefanty AG; Stanley EG; Labonne T; Bateman JF; Lamandé SR
Stem Cell Res; 2020 Jan; 42():101689. PubMed ID: 31884373
[TBL] [Abstract][Full Text] [Related]
15. Generation of human GAPDH knock-in reporter iPSC lines for stable expression of tdTomato in pluripotent and differentiated culture conditions.
Kamiya D; Yamashita T; Akaboshi T; Yamaguchi Y; Toyooka Y; Ikeya M
Stem Cell Res; 2022 Apr; 60():102704. PubMed ID: 35176664
[TBL] [Abstract][Full Text] [Related]
16. Generation of an EFNB2-2A-mCherry reporter human embryonic stem cell line using CRISPR/Cas9-mediated site-specific homologous recombination.
Huang Y; Wu H; Han X; Wu J; Yu M; Zhao ZA; Shen Z; Hu S; Lei W
Stem Cell Res; 2021 Apr; 52():102241. PubMed ID: 33611045
[TBL] [Abstract][Full Text] [Related]
17. Evidence of Adult Features and Functions of Hepatocytes Differentiated from Human Induced Pluripotent Stem Cells and Self-Organized as Organoids.
Messina A; Luce E; Benzoubir N; Pasqua M; Pereira U; Humbert L; Eguether T; Rainteau D; Duclos-Vallée JC; Legallais C; Dubart-Kupperschmitt A
Cells; 2022 Feb; 11(3):. PubMed ID: 35159346
[TBL] [Abstract][Full Text] [Related]
18. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
[TBL] [Abstract][Full Text] [Related]
19. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
[TBL] [Abstract][Full Text] [Related]
20. Generation of a human ACTA1-tdTomato reporter iPSC line using CRISPR/Cas9 editing.
Houweling PJ; Crossman V; Tiong CF; Coles CA; Taylor RL; Clayton JS; Graham A; Vlahos K; Howden SE; North KN
Stem Cell Res; 2024 Mar; 75():103313. PubMed ID: 38277710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
